Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
The American Journal of Sports Medicine
|
February 7, 2023
Denosumab Use in Rats: Letter to the Editor
Paul Kostenuik
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
October 16, 2016
Fracture healing physiology and the quest for therapies for delayed healing and nonunion
Paul Kostenuik, Faisal M Mirza
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 28, 2006
RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis
Harry K W Kim, Stephanie Morgan-Bagley, Paul Kostenuik
JBMR Plus
|
April 18, 2022
Proximal Femur Responses to Sequential Therapy With Abaloparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis by 3D Modeling of Hip Dual-Energy X-Ray Absorptiometry (DXA)
Renaud Winzenrieth, Paul Kostenuik, John Boxberger, et al.
Current Osteoporosis Reports
|
September 26, 2024
Extra-osseous Roles of the RANK-RANKL-OPG Axis with a Focus on Skeletal Muscle
John Gostage, Paul Kostenuik, Katarzyna Goljanek-Whysall, et al.
Menopause (New York, N.Y.)
|
February 25, 2025
Effect of abaloparatide on fracture incidence and bone mineral density in postmenopausal women with osteoporosis at highest risk for fracture
Kristi Tough DeSapri, Bart L Clarke, Paul Kostenuik, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
January 16, 2022
Abaloparatide Effects on Cortical Volumetric BMD and Estimated Strength Indices of Hip Subregions by 3D-DXA in Women With Postmenopausal Osteoporosis
Renaud Winzenrieth, Ludovic Humbert, John I Boxberger, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
February 22, 2019
Abaloparatide, a PTH receptor agonist with homology to PTHrP, enhances callus bridging and biomechanical properties in rats with femoral fracture
Beate Lanske, Heidi Chandler, Allen Pierce, et al.
Bone
|
December 14, 2011
Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice
Mohammad Shahnazari, Denise Dwyer, Vivian Chu, et al.
The American Journal of Pathology
|
April 25, 2009
Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor
Masanobu Ohishi, Riccardo Chiusaroli, Michael Ominsky, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
The American Journal of Sports Medicine
|
February 7, 2023
Denosumab Use in Rats: Letter to the Editor
Paul Kostenuik
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
October 16, 2016
Fracture healing physiology and the quest for therapies for delayed healing and nonunion
Paul Kostenuik, Faisal M Mirza
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 28, 2006
RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis
Harry K W Kim, Stephanie Morgan-Bagley, Paul Kostenuik
JBMR Plus
|
April 18, 2022
Proximal Femur Responses to Sequential Therapy With Abaloparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis by 3D Modeling of Hip Dual-Energy X-Ray Absorptiometry (DXA)
Renaud Winzenrieth, Paul Kostenuik, John Boxberger, et al.
Current Osteoporosis Reports
|
September 26, 2024
Extra-osseous Roles of the RANK-RANKL-OPG Axis with a Focus on Skeletal Muscle
John Gostage, Paul Kostenuik, Katarzyna Goljanek-Whysall, et al.
Menopause (New York, N.Y.)
|
February 25, 2025
Effect of abaloparatide on fracture incidence and bone mineral density in postmenopausal women with osteoporosis at highest risk for fracture
Kristi Tough DeSapri, Bart L Clarke, Paul Kostenuik, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
January 16, 2022
Abaloparatide Effects on Cortical Volumetric BMD and Estimated Strength Indices of Hip Subregions by 3D-DXA in Women With Postmenopausal Osteoporosis
Renaud Winzenrieth, Ludovic Humbert, John I Boxberger, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
February 22, 2019
Abaloparatide, a PTH receptor agonist with homology to PTHrP, enhances callus bridging and biomechanical properties in rats with femoral fracture
Beate Lanske, Heidi Chandler, Allen Pierce, et al.
Bone
|
December 14, 2011
Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice
Mohammad Shahnazari, Denise Dwyer, Vivian Chu, et al.
The American Journal of Pathology
|
April 25, 2009
Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor
Masanobu Ohishi, Riccardo Chiusaroli, Michael Ominsky, et al.
Page
of 4